First Trust Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.71M | Buy |
+152,273
| New | +$2.71M | ﹤0.01% | 1682 |
|
2023
Q1 | – | Sell |
-78,639
| Closed | -$5.77M | – | 2439 |
|
2022
Q4 | $5.77M | Buy |
78,639
+71,782
| +1,047% | +$5.27M | 0.01% | 1130 |
|
2022
Q3 | $521K | Buy |
+6,857
| New | +$521K | ﹤0.01% | 2194 |
|
2022
Q1 | – | Sell |
-27,455
| Closed | -$2.06M | – | 2573 |
|
2021
Q4 | $2.06M | Sell |
27,455
-211,948
| -89% | -$15.9M | ﹤0.01% | 1781 |
|
2021
Q3 | $27.8M | Buy |
239,403
+156,541
| +189% | +$18.2M | 0.03% | 655 |
|
2021
Q2 | $18.4M | Sell |
82,862
-111,914
| -57% | -$24.8M | 0.02% | 814 |
|
2021
Q1 | $25.7M | Sell |
194,776
-73,732
| -27% | -$9.75M | 0.03% | 621 |
|
2020
Q4 | $46.5M | Buy |
+268,508
| New | +$46.5M | 0.06% | 439 |
|
2020
Q3 | – | Sell |
-43,744
| Closed | -$2.59M | – | 2423 |
|
2020
Q2 | $2.59M | Sell |
43,744
-22,248
| -34% | -$1.32M | ﹤0.01% | 1250 |
|
2020
Q1 | $4.44M | Sell |
65,992
-10,472
| -14% | -$705K | 0.01% | 910 |
|
2019
Q4 | $6.44M | Sell |
76,464
-15,520
| -17% | -$1.31M | 0.01% | 992 |
|
2019
Q3 | $6.88M | Sell |
91,984
-4,959
| -5% | -$371K | 0.01% | 935 |
|
2019
Q2 | $6.13M | Sell |
96,943
-2,070
| -2% | -$131K | 0.01% | 955 |
|
2019
Q1 | $4.77M | Sell |
99,013
-8,533
| -8% | -$411K | 0.01% | 1042 |
|
2018
Q4 | $3.6M | Sell |
107,546
-67,662
| -39% | -$2.27M | 0.01% | 1146 |
|
2018
Q3 | $9.18M | Buy |
175,208
+32,543
| +23% | +$1.71M | 0.02% | 863 |
|
2018
Q2 | $4.47M | Buy |
142,665
+28,341
| +25% | +$887K | 0.01% | 1155 |
|
2018
Q1 | $2.49M | Sell |
114,324
-29,831
| -21% | -$650K | 0.01% | 1337 |
|
2017
Q4 | $2.91M | Buy |
+144,155
| New | +$2.91M | 0.01% | 1286 |
|